<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<html>
<head>
<title>Prevalence of active chronic hepatitis B among the HBsAg-carriers in Smolensk, Russia</title>
<meta name="description" content="V.Rafalski, N.Sudilovskaya, E.Karakina. Prevalence of active chronic hepatitis B among the HBsAg-carriers in Smolensk, Russia">
<meta name="keywords" content="Active, chronic hepatitis B, HBsAg-carriers, Smolensk, Russia, Rafalski, Sudilovskaya, Karakina">
<script language="JavaScript1.2"> <!--//
function btn(ind,picture) {document.images[ind].src=picture;}
//--> </script>

<script language="JavaScript"> <!--// 
document.write('<link rel="StyleSheet" type="text/css" href="/en/inc/');
if (navigator.appName=="Netscape") {
	document.write("nn")
} else {
	document.write("ie")
}
document.write('.css">');
//-->
</script>
<noscript><link rel="StyleSheet" type="text/css" href="../../inc/ie.css"></noscript>

<style type="text/css">
P {margin-top:10px; margin-left:10px; text-align:justify;}
LI {margin-top:8px; margin-left:15px; text-align:justify;}
H4 {margin-left:10px;}
H5 {font-size:11pt}
H5.l {text-align:left;}
</style>
</head>

<body class="main">

<table width="750" cellpadding="0" border="0" cellspacing="5">
<tr>
  <th width="150" valign="top">

  <table border="0" cellpadding="5" cellspacing="0" width="100%">
    <tr><td>
<p class="m10"><b>Antimicrobial Resistance</b></p>
<hr size="1" style="color: #D0C0AC;">
<p class="m8"><a href="../index.shtml#rus">Antimicrobial Resistance in Russia</a></p>
<p class="m8"><a href="../index.shtml#pub">Publications</a></p>
<p class="m8"><a href="../links.shtml">References</a></p>

    </td></tr>
  </table>
  

  </th><td valign="top">
<!--navigation-->
<map name="TopBtnEn">
<area shape="circle" coords="15,15,15" href="javascript:history.go(-1)" alt="Previous page" title="Previous page">
<area shape="circle" coords="46,15,15" href="javascript:history.go(+1)" alt="Next page" title="Next page">
<area shape="circle" coords="77,15,15" href="../../index-1.htm" alt="Main page" title="Main page">
<area shape="circle" coords="108,15,15" href="mailto:website@antibiotic.ru" alt="E-Mail" title="E-Mail">
</map>
<table border="0" cellpadding="0" cellspacing="0" width="100%"> <!--1-->
<tr>
  <td bgcolor="#F8F3E6" background="/rus/images/buttons/topline.gif" style="background-color: #F8F3E6; background-image: url(../../../rus/images/buttons/topline.gif);" width="98%" height="32"><img src="../../../rus/images/inv.gif" width="1" height="32" border="0" alt=""></td>
  <td width="1%"><font size="1"><img src="../../../rus/images/buttons/topbtn.gif" width="126" height="32" border="0" alt="Navigation" usemap="#TopBtnEn"></font></td>
</tr>
</table>
<!--/navigation-->

<h2><a name="top"></a>4<sup>th</sup> European Congress of Chemotherapy and Infection</h2>

<h5><i>4–7 May, 2002, Paris, France</i><br></h5>
<!--<h5><b>Poster # </b></h5>-->

<h1>Prevalence of active chronic hepatitis B among the HBsAg-carriers in Smolensk, Russia</h1>

<h5><i>V.&nbsp;Rafalski, N.&nbsp;Sudilovskaya, E.&nbsp;Karakina</i></h5>

<h5 style="font-size:10pt; text-align:left; margin-left:10px;"><i>Institute of Antimicrobial Chemotherapy, State Medical Academy, Smolensk, Russia</i></h5>

<p><i>Correspondence to: V.&nbsp;Rafalski <a href="mailto:raf@antibiotic.ru">raf@antibiotic.ru</a></i></p>

<p style="text-align:right; font-size:8pt"><a target="_blank" href="../../pdfs/raf.pdf">The PDF format poster (331 kb) <img src="../../images/pdf.gif" width="16" height="16" alt="" border="0"></a></p>

<hr size="1">
<ul>
  <li><a href="#1">Abbreviations</a></li>
  <li><a href="#2">Introduction</a></li>
  <li><a href="#3">Aims</a></li>
  <li><a href="#4">Methods</a></li>
  <li><a href="#5">Results</a></li>
  <li><a href="#6">Conclusions</a></li>
  <li><a href="#7">References</a></li>
</ul>
<hr size="1">

<a name="1"></a><br>
<h2>ABBREVIATIONS</h2>

<p>ALT - alanine aminotransferase</p>
<p>Anti-HBe - antibody to hepatiti В е antigen</p>
<p>CBH - chronic hepatitis В</p>
<p>HBV - hepatitis В virus</p>
<p>HBsAg - hepatitis В surface antigen</p>
<p>HBeAg - hepatiti В е antigen</p>
<p>PCR - polymerase chain reaction</p>

<a name="2"></a><br>
<h2>INTRODUCTION</h2>

<p>The diagnosis of chronic HBV infection is based on the persistence of HBsAg&nbsp;&gt; 6&nbsp;months. Earlier the diagnosis of chronic hepatitis&nbsp;В (СНВ) was thought to require the presence of hepatitis&nbsp;В&nbsp;е antigen (HBeAg) and HBsAg+/HBeAg- individuals were considered to have nonreplicative HBV infection. Now serum HBVDNA assays should be performed to determine if the patient should be considered for antiviral therapy.</p>

<a name="3"></a><br>
<h2>AIMS</h2>

<p>To evaluate the incidence of HBV DNA+ ampng HBsAg+ patients and estimate the level of viraemia both in HBeAg(+)/HBsAg(+) and HBeAg(-)/anti-HBeAg(+)/HBsAg(+) patients. To study the ratio of patients who have criteria of active СНВ among HBsAg carriers.</p>

<a name="4"></a><br>
<h2>METHODS</h2>

<p>In this observational study were included 170 patients&nbsp;&gt; 18 years of age with documented HBsAg-carrier&nbsp;&gt; 6&nbsp;months (average age - 40.0 years, male - 56%, female - 44%). HBV DNA in serum was tested by qualitative and quantitative PCR (commercial test-system Ampli-Sens HBV), sensitivity 500&nbsp;copies/ml. HBeAg, HBeAb, HBsAg, anti-HCV, anti-HDV, anti-HIV were detected by ELISA (Hoffmann La Roche). Clinical chemistry (ALT, AST level) was assessed by automatic analyser HUMALYZER 2000.</p>

<p>СНВ criteria from AASLD Practice Guidelines, 2001 was used <a href="#lit1">[1]</a>. All patients were HCV, HDV and HIV negative.</p>

<a name="5"></a><br>
<h2>RESULTS</h2>

<p>51.5% of HBsAg carriages were HBV DNA positive by qualitative PCR. HBeAg was detected in 7.5% patients. HBV DNA in the concentration&nbsp;&gt;10*5&nbsp;copies/ml assessed by quantitative PCR was detected in 22.2% patients (<a href="#f1">fig.&nbsp;1</a>). The HBV DNA level&nbsp;&gt;10*5&nbsp;copies/ml was detected in 100% HBeAg(+) and in 28.6% HBeAg(-) patients (<a href="#f2">fig.&nbsp;2</a>).</p>

<a name="f1"></a><br>
<div align="center"><font size="1"><img src="images/raf1.gif" width="288" height="223" alt="Level of HBV DNA among HBsAg carries" border="0"></font></div>
<p><b>Figure 1.</b> Level of HBV DNA among HBsAg carries</p><br>

<p>The average HBV DNA level was 1.2х10*9&nbsp;copies/ml in the HBeAg(+) patients and 1.4х10*7&nbsp;copies/ml in HBeAg(-) patients (p-Wilcox&nbsp;&lt; 0.001). Elevated ALT level (&gt;&nbsp;x1.5 the upper limit of normal - ULN) was determined in 5.4% of the HBV DNA- and 30.1% of the HBV DNA+   HBsAg carriages. 66.7% of HBVDNA+/HBeAg+ and 16.7% HBVDNA+/HBeAg-HBsAg carriers have 1.5 ULN or higher increase of the ALT level (<a href="#f2">fig.&nbsp;2</a>).</p>

<p>14.1% of all and 12.6% of HBeAg-/anti-HBeAg+ HBsAg carriers had the combination of the biochemical, serological and virology criteria, which are typical for active СНВ (HBsAg-carrier&nbsp;&gt; 6&nbsp;months, HBV DNA &gt;10*5&nbsp;copies/ml, ALT &gt;x1.5 ULN).</p>

<a name="f2"></a><br>
<div align="center"><font size="1"><img src="images/raf2.gif" width="307" height="262" alt="Patients features depending on HBeAg presence" border="0"></font></div>
<p><b>Figure 2.</b> Patients features depending on HBeAg presence</p><br>

<a name="6"></a><br>
<h2>CONCLUSIONS</h2>

<ol>
  <li>51.5% of HBsAg-carriers had viral replication confirmed by PCR.</li>
  <li>14,1% of them had biochemical, serological and virology signs of active chronic hepatitis&nbsp;B.</li>
  <li>Not only HBeAg(+) but also 12.6% of HBeAg(-)/anti-HBeAg(+) patients had characteristic typical for active СНВ and requred an antiviral therapy.</li>
</ol>

<a name="7"></a><a name="lit1"></a><br>
<h2>REFERENCES</h2>

<ol>
  <li>Lok A.S., McMahon B.J. Chronic hepatitis&nbsp;B. Hepatology, 2001 Dec; Vol.&nbsp;34&nbsp;(6), pp.&nbsp;1225-41.</li>
</ol>

<br>
<!-- begin footer -->
<table border="0" cellpadding="5" cellspacing="0" width="100%">
<tr>
  <td style="text-align: left; vertical-align: bottom;" align="left" valign="bottom"><div class="t8">&copy; 2000-2006 IAC SSMA &middot; E-mail: <a href="mailto:website@antibiotic.ru" title="Send e-mail">website&#64;antibiotic&#46;ru</a></div></td>
  <td colspan="2" valign="top" align="right"><font size="1"><!-- SpyLOG v2 f:0211 --><script language="javascript">
u="u607.38.spylog.com";d=document;nv=navigator;na=nv.appName;p=1;
bv=Math.round(parseFloat(nv.appVersion)*100);
n=(na.substring(0,2)=="Mi")?0:1;rn=Math.random();z="p="+p+"&rn="+rn;y="";
y+="<a href='http://"+u+"/cnt?f=3&p="+p+"&rn="+rn+"' target=_blank>";
y+="<img src='http://"+u+"/cnt?"+z+
"&r="+escape(d.referrer)+"&pg="+escape(window.location.href)+"' border=0  width=88 height=31  alt='SpyLOG'>";
y+="</a>"; d.write(y);if(!n) { d.write("<"+"!--"); }//--></script><noscript>
<a href="../../../index-15.htm?f=3&p=1" target="_blank">
<img src="../../../digits.png?p=1" alt='SpyLOG' border='0' width="88" height="31">
</a></noscript><script language="javascript1.2"><!--
if(!n) { d.write("--"+">"); }//--></script><!-- SpyLOG  --></font></td>
</tr>
</table>
<!-- end of footer -->

  </td></tr>
</table>
</body>
</html>
